DE602004016943D1 - Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung - Google Patents

Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung

Info

Publication number
DE602004016943D1
DE602004016943D1 DE602004016943T DE602004016943T DE602004016943D1 DE 602004016943 D1 DE602004016943 D1 DE 602004016943D1 DE 602004016943 T DE602004016943 T DE 602004016943T DE 602004016943 T DE602004016943 T DE 602004016943T DE 602004016943 D1 DE602004016943 D1 DE 602004016943D1
Authority
DE
Germany
Prior art keywords
library
proteom
analysis
production
membrane proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004016943T
Other languages
English (en)
Inventor
Kenji Tanaka
Lyang-Ja Lee
Koji Munechika
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protosera Inc
Original Assignee
Protosera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protosera Inc filed Critical Protosera Inc
Publication of DE602004016943D1 publication Critical patent/DE602004016943D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE602004016943T 2003-07-17 2004-07-16 Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung Expired - Lifetime DE602004016943D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/622,002 US20050032113A1 (en) 2003-07-17 2003-07-17 Membrane protein library for proteome analysis and method for preparing same
PCT/JP2004/010540 WO2005007679A1 (en) 2003-07-17 2004-07-16 Membrane protein library for proteome analysis and method for preparing same

Publications (1)

Publication Number Publication Date
DE602004016943D1 true DE602004016943D1 (de) 2008-11-20

Family

ID=34079745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016943T Expired - Lifetime DE602004016943D1 (de) 2003-07-17 2004-07-16 Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung

Country Status (10)

Country Link
US (2) US20050032113A1 (de)
EP (1) EP1556408B1 (de)
JP (1) JP2008500950A (de)
KR (1) KR20060119694A (de)
CN (1) CN100404546C (de)
AT (1) ATE410436T1 (de)
AU (1) AU2004257084A1 (de)
CA (1) CA2499024A1 (de)
DE (1) DE602004016943D1 (de)
WO (1) WO2005007679A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514555D0 (en) * 2005-07-15 2005-08-24 Nonlinear Dynamics Ltd A method of analysing separation patterns
GB0514553D0 (en) * 2005-07-15 2005-08-24 Nonlinear Dynamics Ltd A method of analysing a representation of a separation pattern
US8541190B2 (en) * 2006-06-28 2013-09-24 Robert M. Weis Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
JP2008020383A (ja) * 2006-07-14 2008-01-31 Sapporo Medical Univ リポソームをリガンドとして用いた体液タンパク質の解析方法及び体液タンパク質の調製方法
CN106039307A (zh) 2008-08-05 2016-10-26 东丽株式会社 用于治疗和预防癌症的药物组合物
KR101606779B1 (ko) * 2008-08-05 2016-03-28 도레이 카부시키가이샤 암의 검출 방법
CN101338454B (zh) * 2008-08-27 2011-09-21 中国科学技术大学 一种构建膜蛋白cDNA文库的方法及其应用
HUE030102T2 (en) 2010-02-04 2017-04-28 Toray Industries A pharmaceutical composition comprising anti-caprin-1 antibodies for the treatment and / or prevention of cancer
BR112012018951C8 (pt) 2010-02-04 2020-06-23 Toray Industries anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica
KR101758117B1 (ko) 2010-02-04 2017-07-14 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
CN102822335B (zh) 2010-02-04 2015-09-30 东丽株式会社 癌的治疗和/或预防用药物组合物
CN102821788B (zh) 2010-02-04 2016-11-16 东丽株式会社 癌的治疗和/或预防用药物组合物
KR101843807B1 (ko) 2010-02-04 2018-03-30 도레이 카부시키가이샤 암의 치료 및/또는 예방을 위한 의약품
CN102443047B (zh) * 2010-10-12 2014-11-19 上海医药工业研究院 一种顶头孢霉蛋白质组的制备方法
EP2740793B1 (de) 2011-08-04 2017-11-29 Toray Industries, Inc. Arzneimittelzusammensetzung zur krebsbehandlung und/oder vorbeugung
MX351414B (es) 2011-08-04 2017-10-13 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico.
JP6065592B2 (ja) 2011-08-04 2017-01-25 東レ株式会社 癌の治療及び／又は予防用医薬組成物
DK2740794T3 (en) 2011-08-04 2018-06-14 Toray Industries PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION
HUE033628T2 (en) 2011-08-04 2017-12-28 Toray Industries Method for detecting pancreatic cancer
WO2013018894A1 (ja) 2011-08-04 2013-02-07 東レ株式会社 癌の治療及び／又は予防用医薬組成物
KR101980554B1 (ko) 2011-08-04 2019-05-21 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
MX363136B (es) 2012-02-21 2019-03-12 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
PL2818483T3 (pl) 2012-02-21 2018-01-31 Toray Industries Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi
EP2818482B1 (de) 2012-02-21 2019-05-22 Toray Industries, Inc. Pharmazeutische zusammensetzung zur behandlung und von krebs
BR112014021103A2 (pt) 2012-02-21 2019-10-15 Toray Industries, Inc Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
KR102052400B1 (ko) 2012-03-30 2019-12-06 도레이 카부시키가이샤 담낭암의 치료 및/또는 예방용 의약 조성물
HUE036424T2 (hu) 2012-03-30 2018-07-30 Toray Industries Gyógyászati készítmény májrák kezelésére és/vagy megelõzésére
WO2014014082A1 (ja) 2012-07-19 2014-01-23 東レ株式会社 癌の検出方法
CA2879185C (en) 2012-07-19 2021-08-24 Toray Industries, Inc. Method for detecting cancer
CN105452294B (zh) 2013-08-09 2019-08-02 东丽株式会社 癌的治疗和/或预防用药物组合物
CN112813505A (zh) * 2020-12-30 2021-05-18 上海交通大学 一种抗原抗体共展示方法用于膜抗原的抗体文库筛选
CN117542460B (zh) * 2024-01-09 2024-03-22 江苏尤里卡生物科技有限公司 用于尿激酶分离的自适应参数优化方法及系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789734A (en) * 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
JPH06247842A (ja) * 1993-02-23 1994-09-06 Green Cross Corp:The リポソーム組成物の製造方法
US5776486A (en) * 1993-05-28 1998-07-07 Aphios Corporation Methods and apparatus for making liposomes containing hydrophobic drugs
EP1347493A3 (de) * 1993-05-28 2005-11-23 Baylor College Of Medicine Verfahren und Gerät zur Desorption und Ionisierung von Analyte
US20020037517A1 (en) * 1993-05-28 2002-03-28 Hutchens T. William Methods for sequencing biopolymers
US6020208A (en) * 1994-05-27 2000-02-01 Baylor College Of Medicine Systems for surface-enhanced affinity capture for desorption and detection of analytes
US6071610A (en) * 1993-11-12 2000-06-06 Waters Investments Limited Enhanced resolution matrix-laser desorption and ionization TOF-MS sample surface
DE4408034C1 (de) * 1994-03-10 1995-07-13 Bruker Franzen Analytik Gmbh Verfahren zur massenspektrometrischen Analyse von Proben aus 2D-Gel-Elektrophoreseplatten mit matrixunterstützter ionisierender Laser-Desorption
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6217901B1 (en) * 1999-05-25 2001-04-17 Alnis, Llc Liposome-assisted synthesis of polymeric nanoparticles
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
ATE348191T1 (de) * 2000-07-03 2007-01-15 Applera Corp Polynukleotid-sequenzassay
US7276579B2 (en) * 2000-12-27 2007-10-02 Dana-Farber Cancer Institute, Inc. Immunogenic proteoliposomes, and uses thereof
US20030044843A1 (en) * 2001-01-09 2003-03-06 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor
US20030129666A1 (en) * 2001-01-09 2003-07-10 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor

Also Published As

Publication number Publication date
CA2499024A1 (en) 2005-01-27
CN100404546C (zh) 2008-07-23
EP1556408B1 (de) 2008-10-08
ATE410436T1 (de) 2008-10-15
JP2008500950A (ja) 2008-01-17
EP1556408A1 (de) 2005-07-27
CN1705676A (zh) 2005-12-07
US20060035276A1 (en) 2006-02-16
WO2005007679A1 (en) 2005-01-27
AU2004257084A1 (en) 2005-01-27
KR20060119694A (ko) 2006-11-24
US20050032113A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
DE602004016943D1 (de) Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung
DE60325847D1 (de) Verbindungen und verfahren für die analyse des proteoms
ATE469692T1 (de) Verbessertes verfahren zum wickeln von z- filtermedien
DE602004015408D1 (de) Verfahren zur analyse von polymer-populationen
ATE470722T1 (de) Strategien zur genexpressionsanalyse
ATE369201T1 (de) Verfahren zur reinigung von synthesegas
DE60216389D1 (de) Verfahren zur zerstörungsfreien Prüfung
ATE467301T1 (de) Verfahren und vorrichtung für gleichrangigen diensten
ATE459652T1 (de) Verfahren zur herstellung von antikörpern
DE60128159D1 (de) Vorrichtung zur reformierung von Brennstoff
DE60317136D1 (de) Immuntestverfahren, Reagenz für Immuntestverfahren und Verfahren zu dessen Herstellung
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
HK1074252A1 (en) Method for identifying and extracting endotoxin
DE602004020550D1 (de) Verfahren zur Untersuchung von Halbleitern
DE60202161D1 (de) Verfahren, Vorrichtung und Programm zur Analyse und Synthese von Sprache
ATE288589T1 (de) Verfahren zur analyse von proteinen
DE60210606D1 (de) Verfahren zur herstellung von hochfestem tetrafluorethylenpolymer
ATE405592T1 (de) Verfahren zur bildung eines protein- mikroarraysystems
SE0300612D0 (sv) A method of preparing ligands for hydrophobic interaction chromatography
DK1624949T3 (da) Membranapparat og fremgangsmåde til fremstilling af en membran og fremgangsmåde til fremstilling af syntetisk gas
DE10293380D2 (de) Verfahren zur Konfigurierung paralleler Nukleinsäureanalyseverfahren zur Sequenzmengenklassifikation
DE602004011505D1 (de) Verfahren zur chromatographischen analyse einer proteinlösung
ATE412187T1 (de) Screening test
EP1634960A4 (de) Sonden zur analyse der wechselwirkung zwischen proteinen und verfahren zur analyse der wechselwirkung zwischen proteinen damit
DE60212363D1 (de) Verfahren zur herstellung von verstärktem platinmaterial

Legal Events

Date Code Title Description
8364 No opposition during term of opposition